OLADELE ADEBOGUN: Open Payments
NPI 1104822097 · FLOWER MOUND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,110 in 373 payments from 23 companies in 2025. Trend: 2023 $6,509 · 2024 $5,898 · 2025 $6,110
Food & beverage: $6,100Education: $10
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 40 | $876 |
| E.R. Squibb & Sons, L.L.C. | 53 | $627 |
| Corium, LLC | 21 | $609 |
| Otsuka America Pharmaceutical, Inc. | 33 | $592 |
| ABBVIE INC. | 31 | $509 |
| Supernus Pharmaceuticals, Inc. | 69 | $489 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $394 |
| Lundbeck LLC | 16 | $298 |
| Axsome Therapeutics, Inc. | 14 | $281 |
| Alkermes, Inc. | 15 | $232 |
Products named: CAPLYTA, REXULTI, COBENFY, Azstarys, VRAYLAR, Qelbree, TRINTELLIX, Auvelity.
Industry payments across TX — which companies pay providers there.
